GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Genomic Valley Biotech Ltd

Genomic Valley Biotech: Open Offer for 7,94,170 Equity Shares by Acquirers

M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 27 Oct 2026, 03:14 PM IST  ·  BSE ID: b6ecda7e-3b10-41fd-9996-fe3c906d8416
View Original BSE Filing (PDF)
💡
In Simple Terms
An Open Offer has been announced for Genomic Valley Biotech to acquire up to 7,94,170 shares from existing shareholders.
🤖 AI Summary
  • Detailed Public Statement submitted for Open Offer in Genomic Valley Biotech Limited (GVBL).
  • Acquirers Mr. Pankaj Grover and Mr. Abhisek Gupta initiating the Open Offer.
  • Offer aims to acquire up to 7,94,170 equity shares from GVBL shareholders.
  • Statement published in Financial Express, Jansatta, and Mumbai Lakshadeep on October 27, 2026.
  • Submission made by Fintellectual Corporate Advisors, Manager to the Open Offer.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares to be Acquired
7,94,170 Equity Shares
🏢 How This Affects the Company
⚠️
Risk Impact
Shareholders face a decision regarding participation in the Open Offer, which involves selling their equity shares to the acquirers. The completion of the open offer will result in a change in the shareholding structure of Genomic Valley Biotech Ltd.
👥 What This Means For Shareholders
✅
Action Required
Shareholders of Genomic Valley Biotech Limited should review the Detailed Public Statement to understand the terms and conditions of the Open Offer.
👤
Who Is Affected
All shareholders of Genomic Valley Biotech Limited are affected as the Open Offer provides an opportunity to tender up to 7,94,170 of their equity shares.
🔍
Management Signal
The Open Offer indicates a strategic move by Mr. Pankaj Grover and Mr. Abhisek Gupta to acquire a substantial stake in Genomic Valley Biotech Limited.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Open Offer schedule – check for offer period and payment dates.
Acquirers' future plans – monitor any subsequent disclosures on company strategy.
Final shareholding structure – verify post-offer ownership distribution.
MEDIUM RISK Changes in ownership and management structure can introduce new strategic and operational risks.
💡 Investor Takeaway
An Open Offer is announced for Genomic Valley Biotech Limited to acquire up to 7,94,170 equity shares. Mr. Pankaj Grover and Mr. Abhisek Gupta are the acquirers. A Detailed Public Statement was published on October 27, 2026.
❓ Frequently Asked Questions
What is the purpose of the recent filing by Genomic Valley Biotech Ltd?
The filing is a Detailed Public Statement for an Open Offer to acquire up to 7,94,170 equity shares of Genomic Valley Biotech Limited from its shareholders.
Who are the acquirers in the Open Offer for Genomic Valley Biotech?
The acquirers in the Open Offer are Mr. Pankaj Grover (Acquirer 1) and Mr. Abhisek Gupta (Acquirer 2).
How many equity shares are being targeted in the Open Offer for Genomic Valley Biotech?
The Open Offer targets the acquisition of up to 7,94,170 equity shares from the shareholders of Genomic Valley Biotech Limited.
When was the Detailed Public Statement for the Open Offer published?
The Detailed Public Statement was published on Tuesday, October 27, 2026, in newspapers including Financial Express, Jansatta, and Mumbai Lakshadeep.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.